Search

Search Constraints

You searched for: Author/Creator Lionakis, Michail

Search Results

1. 1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies. (26th November 2018)

2. 149. Efficacy of Cochleated Amphotericin B (CAMB) in Mouse and Human Mucocutaneous Candidiasis. (31st December 2020)

4. 42. Common Population Variants Cause Susceptibility to Disseminated Coccidioidomycosis. (31st December 2020)

7. Colitis susceptibility in p47phox−/− mice is mediated by the microbiome. Issue 1 (December 2016)

9. The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes. Issue 1 (December 2018)

10. VT-1598 Inhibits the in vitro Growth of Mucosal Candida Isolates and Protects Against Oropharyngeal Candidiasis in IL-17 Deficient Mice. (4th October 2017)